lobbying_activities: 2962802

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2962802	99b60aba-9bfc-4737-bdc1-717baefad4bc	Q1	GOVERNMENT COUNSEL, LLC	401105070	HEALTHCARE DISTRIBUTION ALLIANCE	2023	first_quarter	PHA	H.R. 501-Block, Report, And Suspend Suspicious Shipments Act; General issues relating access to medication assisted treatment.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE	60000		0	0	2023-04-17T18:06:02-04:00